Your browser doesn't support javascript.
loading
Delayed Presentation of Pityriasis Rubra Pilaris in a Patient on Treatment With Ponatinib.
Yaldo, Marissa M; Olds, Hailey; Hengy, Meredith; Moossavi, Meena.
Afiliação
  • Yaldo MM; School of Medicine, Wayne State University, Detroit, USA.
  • Olds H; Department of Dermatology, Wayne State University School of Medicine, Detroit, USA.
  • Hengy M; School of Medicine, Wayne State University, Detroit, USA.
  • Moossavi M; Department of Dermatology, Wayne State University School of Medicine, Detroit, USA.
Cureus ; 16(1): e52155, 2024 Jan.
Article em En | MEDLINE | ID: mdl-38344497
ABSTRACT
Pityriasis rubra pilaris (PRP) is a rare dermatologic condition whose etiology is largely unknown. However, some medications, including ponatinib, have been implicated. Our case features an 80-year-old patient who developed PRP after two-and-a-half years of ponatinib use. We present this case due to the rare presentation of ponatinib-induced PRP as well as its significantly delayed presentation.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos